Literature DB >> 15944314

Involvement of SHIP in TLR2-induced neutrophil activation and acute lung injury.

Derek Strassheim1, Jae-Yeol Kim, Jong-Sung Park, Sanchayita Mitra, Edward Abraham.   

Abstract

The SHIP converts phosphatidylinositol 3,4,5 triphosphate to phosphatidyl 3,4 biphosphate. SHIP has negative regulatory functions on PI3K-dependent signaling pathways, which occupy important roles in modulating neutrophil functions. We used neutrophils from transgenic SHIP(-/-) and SHIP(+/+) mice that were stimulated with peptidoglycan (PGN) to examine the role of SHIP in TLR2-induced neutrophil activation. SHIP(-/-) neutrophils demonstrated significantly increased activation of the PI3K-dependent kinase Akt after exposure to PGN. Release of cytokines and chemokines, including TNF-alpha, IL-1beta, IL-6, IL-10, and MIP-2, was also increased in SHIP(-/-) compared with SHIP(+/+) neutrophils. There was no difference in the nuclear translocation of the transcriptional factor NF-kappaB between PGN-stimulated SHIP(-/-) and SHIP(+/+) neutrophils. However, phosphorylation of the p65 subunit of NF-kappaB, an event essential for optimal transcriptional activity of NF-kappaB, was increased in TLR2-activated SHIP(-/-) neutrophils. SHIP(-/-) neutrophils demonstrated greater activation of ERK1/2 and p38 MAPKs than did SHIP(+/+) neutrophils after exposure to PGN. The severity of acute lung injury induced by PGN was greater in SHIP(-/-) as compared with SHIP(+/+) mice. These results demonstrate that SHIP has a negative regulatory role in TLR2-induced neutrophil activation and in the development of related in vivo neutrophil-dependent inflammatory processes, such as acute lung injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944314     DOI: 10.4049/jimmunol.174.12.8064

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  PTEN negatively regulates engulfment of apoptotic cells by modulating activation of Rac GTPase.

Authors:  Subhanjan Mondal; Saurabh Ghosh-Roy; Fabien Loison; Yitang Li; Yonghui Jia; Chad Harris; David A Williams; Hongbo R Luo
Journal:  J Immunol       Date:  2011-10-31       Impact factor: 5.422

Review 2.  New players in TLR-mediated innate immunity: PI3K and small Rho GTPases.

Authors:  Monica Ruse; Ulla G Knaus
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  Kinase AKT controls innate immune cell development and function.

Authors:  Yan Zhang; Xiao Wang; Hui Yang; Huanrong Liu; Yun Lu; Limei Han; Guangwei Liu
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

4.  Heme oxygenase-1 protects rat liver against warm ischemia/reperfusion injury via TLR2/TLR4-triggered signaling pathways.

Authors:  Han-Fei Huang; Zhong Zeng; Kun-Hua Wang; Hai-Yan Zhang; Shuai Wang; Wen-Xiang Zhou; Zhan-Bo Wang; Wang-Gang Xu; Jian Duan
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

5.  Altered expression of SHIP, a Toll-like receptor pathway inhibitor, is associated with the severity of liver fibrosis in chronic hepatitis C virus infection.

Authors:  Antonios Katsounas; Martin Trippler; Shyam Kottilil; Richard A Lempicki; Guido Gerken; Joerg F Schlaak
Journal:  J Infect Dis       Date:  2011-10-15       Impact factor: 5.226

6.  IMPDHII protein inhibits Toll-like receptor 2-mediated activation of NF-kappaB.

Authors:  Julie Toubiana; Anne-Lise Rossi; David Grimaldi; Nadia Belaidouni; Philippe Chafey; Guilhem Clary; Emilie Courtine; Frederic Pene; Jean-Paul Mira; Yann-Erick Claessens; Jean-Daniel Chiche
Journal:  J Biol Chem       Date:  2011-04-01       Impact factor: 5.157

Review 7.  A role for SHIP in stem cell biology and transplantation.

Authors:  William G Kerr
Journal:  Curr Stem Cell Res Ther       Date:  2008-05       Impact factor: 3.828

8.  Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 2. Efficacy studies in allergic and pulmonary inflammation models in vivo.

Authors:  Grant R Stenton; Lloyd F Mackenzie; Patrick Tam; Jennifer L Cross; Curtis Harwig; Jeffrey Raymond; Judy Toews; David Chernoff; Thomas MacRury; Csaba Szabo
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

9.  Prostacyclin inhibits IFN-gamma-stimulated cytokine expression by reduced recruitment of CBP/p300 to STAT1 in a SOCS-1-independent manner.

Authors:  Derek Strassheim; Suzzette R Riddle; Danielle L Burke; Mark W Geraci; Kurt R Stenmark
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

10.  MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response.

Authors:  Thomas J Cremer; David H Ravneberg; Corey D Clay; Melissa G Piper-Hunter; Clay B Marsh; Terry S Elton; John S Gunn; Amal Amer; Thirumala-Devi Kanneganti; Larry S Schlesinger; Jonathan P Butchar; Susheela Tridandapani
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.